An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Value in Health. 2014;17(7):A616-7
Rinciog C, Myrén KJ, Aldén M, Diamantopoulos A, LeReun C
Systematic review and adjusted indirect comparison of orphan drugs for adults with progressive, unresectable locally advanced or metastatic medullary thyroid cancer.
Several subgroup analyses were conducted using a logrank model and Cox model.
Publications in other disease areas
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke
Societal costs of Er+/Her2- advanced or metastatic breast cancer in post-menopausal women in the United Kingdom
Idiopathic pulmonary fibrosis
The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence review
The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis
Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK
Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective